Predict your next investment

Corporation
RISK & SECURITY | Security Services / Security Consulting & Advisory
centauricorp.com

See what CB Insights has to offer

Service Providers

1

About Centauri

Centauri is an engineering, intelligence, cybersecurity and advanced technology solutions company headquartered in Chantilly, Virginia with offices Nationwide. It works with customers in the intelligence and national security communities, helping them solve their most difficult challenges. The company's agile, mission-first approach empowers our advanced technical and operational teams to meet the real-time demands and high-impact missions of national defense agencies across land, air, sea, space, and cyberspace.On August 19th, 2020, Centauri was acquired by KBR at a valuation of $800M.

Centauri Headquarter Location

15020 Conference Center Drive Suite 100

Chantilly, Virginia, 20151,

United States

703-378-8672

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Centauri

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Centauri in 1 CB Insights research brief, most recently on Oct 28, 2020.

Latest Centauri News

06:25 ET Galaxy Medical Enrolls first Patients in SPACE-AF study

Sep 20, 2021

News provided by Share this article Share this article SAN CARLOS, Calif., Sept. 20, 2021 /PRNewswire/ -- Galaxy Medical announced today the initiation of the SPACE-AF study with enrollment of the first two patients at Southlake Regional Health Centre in Newmarket, Canada. In the study, the CENTAURI Pulsed Electric Field (PEF) ablation system will be used to ablate both the pulmonary veins and posterior walls in patients with persistent atrial fibrillation (AF). Recently, Galaxy has also enrolled additional subjects in the ECLIPSE-AF study using the CARTO mapping system and CE-Marked catheters manufactured by Biosense Webster, achieving CENTAURI combatability with the three market leading cardiac mapping systems and their associated catheters. Atul Verma, MD, Head of the Heart Rhythm program at Southlake Regional Health Centre and Primary Investigator in the SPACE-AF study commented: "We are thrilled to launch the first study of focal ablation through a solid tip catheter with PEF to treat both the pulmonary veins and atrial targets beyond the pulmonary veins including the left atrial posterior wall. Patients with persistent atrial fibrillation often require electrical isolation beyond simple pulmonary vein isolation and for years we have been seeking a safe, predictable, and effective energy source to do so. In our first two cases using the CENTAURI focal PEF approach, I customized the lesion sets to each patient in our installed CARTO system. The procedures were nearly identical to our standard radiofrequency ablation cases, but with the added confidence of PEF as compared to thermal modalities. We look forward to reporting on the procedural safety and long-term efficacy results of this study." Expanding on the ECLIPSE-AF trial in Europe, SPACE-AF will enroll up to 30 patients in Canada with persistent atrial fibrillation who require treatment beyond pulmonary vein isolation. After assessing safety and acute efficacy of pulmonary vein and posterior wall focal ablation with the CENTAURI System and approved catheters and mapping systems, patients will be followed to determine efficacy at 6 and 12 months. Presence of acute microbubbles will be graded during the procedure via intracardiac echo (ICE) imaging and cranial MRIs will evaluate for emboli. "CENTAURI was designed to democratize PEF technology, allowing electrophysiologists to use any catheter and mapping system to create any lesion set. The launch of SPACE-AF validates this approach as Dr. Verma delivered PEF through a SMARTTOUCH catheter in CARTO to create a complex lesion set customized to the patient's anatomy, which could not be achieved by any one single shot catheter. Taking an open system approach, it is a major milestone to achieve compatiblity with CARTO, Ensite Precision, and RHYTHMIA HDx as we prepare for the commercial launch of the CENTAURI system in Europe. We look forward to releasing more data soon on microbubble reduction and the long term outcomes from our WAVE1 optimized dosing cohort," said Jonathan Waldstreicher, M.D., CEO of Galaxy Medical. CENTAURI is an investigational device and not commercially available. About Galaxy Medical Galaxy Medical ( www.galaxymed.com ) is a privately held medical device company based in San Carlos, CA, that is dedicated to developing therapies to treat patients with cardiac arrhythmias. Formed by ATP, a leader in life sciences venture capital, Galaxy is building a portfolio of technologies to address the needs of cardiac electrophysiologists. Media Contacts

Centauri Acquisitions

3 Acquisitions

Centauri acquired 3 companies. Their latest acquisition was PreTalen on December 11, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/11/2019

Acquired

1

12/11/2019

Grant - III

Subscribe to see more

$99M

Subscribe to see more

10

9/24/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/11/2019

12/11/2019

9/24/2019

Investment Stage

Grant - III

Companies

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Centauri Service Providers

1 Service Provider

Centauri has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Centauri Team

2 Team Members

Centauri has 2 team members, including former President, Dennis Kelly.

Name

Work History

Title

Status

Dennis Kelly

President

Former

Robert Richards

Chief Financial Officer

Former

Name

Dennis Kelly

Robert Richards

Work History

Title

President

Chief Financial Officer

Status

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.